Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.24.1.1.u2
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development 2,194,513 1,827,907
General and administrative 342,688 413,175
Total operating expenses 2,537,201 2,241,082
Loss from operations (2,537,201) (2,241,082)
Interest income 64,006 116,180
Net loss $ (2,473,195) $ (2,124,902)
Per share information:    
Net loss per common share, basic $ (0.19) $ (0.17)
Net loss per common share, diluted $ (0.19) $ (0.17)
Weighted average common shares outstanding, basic 12,859,685 12,848,165
Weighted average common shares outstanding, diluted 12,859,685 12,848,165